These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26962160)

  • 21. Osteogenic Sarcoma: A 21st Century Review.
    Osasan S; Zhang M; Shen F; Paul PJ; Persad S; Sergi C
    Anticancer Res; 2016 Sep; 36(9):4391-8. PubMed ID: 27630274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of indications and the perspectives of limb salvage surgery in malignant bone tumours in children and youth].
    Wozniak W; Rychlowska M; Kuczabski M; Szafranski A
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):85-93. PubMed ID: 11178332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
    Smeland S; Wiebe T; Böhling T; Brosjö O; Jonsson K; Alvegård TA
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):92-8. PubMed ID: 15188671
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenges of Systemic Therapy Investigations for Bone Sarcomas.
    Nakano K
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone sarcomas: experience of an orthopedic oncology unit in the treatment of 180 consecutive cases, 1988-1995 (Part II)].
    Bickels J; Kollender Y; Nirkin A; Isakov J; Mozes M; Merimsky O; Cohen I; Ben Harush M; Noyman Y; Meller I
    Harefuah; 1998 Mar; 134(5):378-81. PubMed ID: 10909556
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
    Miser JS; Krailo M
    Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeted therapies in bone sarcomas: current approach and future directions.
    Yarber JL; Agulnik M
    Expert Opin Investig Drugs; 2011 Jul; 20(7):973-9. PubMed ID: 21510829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
    Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted therapies in bone sarcomas.
    Scotlandi K; Picci P; Kovar H
    Curr Cancer Drug Targets; 2009 Nov; 9(7):843-53. PubMed ID: 20025572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
    Sampson VB; Kamara DF; Kolb EA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma.
    Duffaud F; Egerer G; Ferrari S; Rassam H; Boecker U; Bui-Nguyen B
    Eur J Cancer; 2012 Mar; 48(4):564-70. PubMed ID: 22243773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates in common pediatric and adult bone sarcomas.
    Heymann MF; Lezot F; Heymann D
    Bone; 2020 Oct; 139():115523. PubMed ID: 32622877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital.
    Khor TH; Chua EJ; Tan BC; Chia KB
    Singapore Med J; 1983 Apr; 24(2):95-8. PubMed ID: 6577611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of chemotherapy in treatment of osteosarcoma].
    Perek D; Jurczyk-Procyk S
    Pediatr Pol; 1995 Nov; 70(11):939-47. PubMed ID: 8677160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in osteosarcoma.
    Botter SM; Neri D; Fuchs B
    Curr Opin Pharmacol; 2014 Jun; 16():15-23. PubMed ID: 24632219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
    Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
    Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
    [No Abstract]   [Full Text] [Related]  

  • 38. Appraising the current role of chemotherapy for the treatment of sarcoma.
    D'Adamo DR
    Semin Oncol; 2011 Oct; 38 Suppl 3():S19-29. PubMed ID: 22055968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Update on pediatric oncology].
    Kalifa C; Grill J; Hartmann O
    Bull Cancer; 1998 Jan; 85(1):57-8. PubMed ID: 9752350
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
    Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
    Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.